ClinOracle: Hierarchical AI Prediction of Target Binding and Patient-Derived Functional Activity Across Diverse Therapeutic Targets
Abdel-Rahman, S.; Gabr, M.
Show abstract
AI platforms for drug discovery routinely achieve high hit rates against biochemical targets, yet the central translational challenge remains predicting whether a compound will be functionally active in patient-derived human cells. Here, we present ClinOracle, a hierarchical graph neural network that jointly predicts target binding and patient-derived functional activity by modeling functional activity as conditional on target engagement. Applied across five therapeutic targets spanning oncology, autoimmune, and neuroinflammatory diseases, ClinOracle ranked candidates using a Priority Score integrating translational probability with a developability score based on ADME and drug-likeness, advancing prioritized compounds through multistage prospective validation from biophysical binding to in vivo efficacy. Compounds with the highest Priority Scores consistently outperformed lower-ranked candidates across prospective experimental validation, demonstrating that hierarchical AI can prioritize compounds with patient-derived functional activity directly from molecular structure, rather than biochemical activity alone.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Community assessment of cancer drug combination screens identifies strategies for synergy prediction 96%
- In silico discovery of nanobody binders to a G-protein coupled receptor using AlphaFold-Multimer 96%
- First fully-automated AI/ML virtual screening cascade implemented at a drug discovery centre in Africa 95%
Similar papers in this journal
- TrustAffinity: accurate, reliable and scalable out-of-distribution protein-ligand binding affinity prediction using trustworthy deep learning 96%
- Sagittarius: Extrapolating Heterogeneous Time-Series Gene Expression Data 94%
- An interpretable deep learning framework for genome-informed precision oncology 93%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.